Open Therapeutics Integrates Overleaf Manuscript Development Platform Into Therapoid™
N E W S R E L E A S E For Immediate Release: 09 January 2018 Open Therapeutics Integrates…
News
Open Therapeutics Integrates Annotation with Hypothesis
Today, Open Therapeutics is announcing the integration of Hypothesis annotation capabilities in Therapoid™, its crowdsourcing platform that enables scientists to collaborate freely on therapeutic biotechnology…
Novartis CAR-T cancer therapy wins expert support for FDA approval
“I think this is most exciting thing I’ve seen in my lifetime,” said Dr. Tim Cripe, an oncologist with Nationwide Children’s Hospital. https://www.statnews.com/2017/07/12/novartis-car-t-fda-approval/
Jason Barkeloo, Chairman and Founder of Open Therapeutics, to speak at the next Xavier Health lunch and learn July 20, 2017
The Next “Big Cure” is Here and Waiting. How can your company benefit? How can you benefit? Thursday, July 20 from 12:00 – 12:30 pm…
Open Therapeutics and the Center for Advancing Innovation Form Partnership
Will collaborate on advancing intellectual property to the global scientific and entrepreneurial communities Open Therapeutics and the Center for Advancing Innovation announce the formation of…
Open Therapeutics’ leadership to attend the BIO International Convention – The Global Event for Biotechnology
Open Therapeutics with be attending The BIO International Convention which is hosted by the Biotechnology Innovation Organization (BIO). BIO represents more than 1,100 biotechnology companies, academic institutions,…
Dr. Li Guo to present at the Science of Team Science (SciTS) 2017 Conference
Li Guo, PhD, who serves as a Scientific Community Manager for Open Therapeutics, to present the new Open Therapeutics platform for scientific collaboration around biotechnologies at the SciTS…
Jerome Hamilton Ranks #31 in the Financial Times’ Annual EMPower List of Top 100 Ethnic Minority Leaders
MINNEAPOLIS – Jerome Hamilton, CEO of Open Therapeutics, has been elected to the Financial Times prestigious annual EMPower list of the Top 100 Ethnic Minority…
Cooperation of Oncolytic Herpes Virotherapy and PD-1 Blockade in Murine Rhabdomyosarcoma Models
http://www.nature.com/articles/s41598-017-02503-8
Open Therapeutics and AuthorAID Announce Partnership
N E W S R E L E A S E For Immediate Release: May 26, 2017 Open Therapeutics and AuthorAID to Cooperate on Advancing…
